Jonathan Ilowite

2.4k total citations
32 papers, 1.7k citations indexed

About

Jonathan Ilowite is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Physiology. According to data from OpenAlex, Jonathan Ilowite has authored 32 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pulmonary and Respiratory Medicine, 5 papers in Epidemiology and 5 papers in Physiology. Recurrent topics in Jonathan Ilowite's work include Inhalation and Respiratory Drug Delivery (10 papers), Cystic Fibrosis Research Advances (9 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (6 papers). Jonathan Ilowite is often cited by papers focused on Inhalation and Respiratory Drug Delivery (10 papers), Cystic Fibrosis Research Advances (9 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (6 papers). Jonathan Ilowite collaborates with scholars based in United States, Canada and Germany. Jonathan Ilowite's co-authors include Gerald C. Smaldone, Anne E. O’Donnell, Alan F. Barker, Robert B. Fick, William D. Bennett, Robert J. Perry, David M. Nierman, Alan M. Fein, Michael S. Niederman and Mitchell Friedman and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Advanced Drug Delivery Reviews and CHEST Journal.

In The Last Decade

Jonathan Ilowite

32 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jonathan Ilowite United States 20 1.5k 436 310 115 101 32 1.7k
J C Yernault Belgium 17 1.5k 1.0× 723 1.7× 237 0.8× 46 0.4× 108 1.1× 36 1.9k
Robert H. Poe United States 22 1.5k 1.0× 620 1.4× 195 0.6× 100 0.9× 148 1.5× 59 1.9k
Gerard J. Canny Canada 21 2.3k 1.5× 599 1.4× 301 1.0× 132 1.1× 80 0.8× 37 2.7k
Tam Eaton New Zealand 10 1.2k 0.8× 367 0.8× 173 0.6× 54 0.5× 72 0.7× 12 1.3k
Jeng‐Yuan Hsu Taiwan 21 837 0.6× 448 1.0× 135 0.4× 55 0.5× 49 0.5× 86 1.3k
D P Heaf United Kingdom 20 961 0.7× 322 0.7× 224 0.7× 67 0.6× 94 0.9× 38 1.4k
F. John McLaughlin Canada 16 1.2k 0.8× 257 0.6× 158 0.5× 79 0.7× 42 0.4× 16 1.5k
Rafał Krenke Poland 23 1.2k 0.8× 532 1.2× 197 0.6× 25 0.2× 106 1.0× 181 1.7k
Paola Faverio Italy 20 935 0.6× 268 0.6× 475 1.5× 49 0.4× 27 0.3× 75 1.6k
Young Sik Park South Korea 25 914 0.6× 238 0.5× 423 1.4× 32 0.3× 84 0.8× 113 1.9k

Countries citing papers authored by Jonathan Ilowite

Since Specialization
Citations

This map shows the geographic impact of Jonathan Ilowite's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Ilowite with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Ilowite more than expected).

Fields of papers citing papers by Jonathan Ilowite

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan Ilowite. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Ilowite. The network helps show where Jonathan Ilowite may publish in the future.

Co-authorship network of co-authors of Jonathan Ilowite

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan Ilowite. A scholar is included among the top collaborators of Jonathan Ilowite based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan Ilowite. Jonathan Ilowite is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ilowite, Jonathan, et al.. (2021). Digital Health Technology and Telemedicine-Based Hospital and Home Programs in Pulmonary Medicine During the COVID-19 Pandemic. American Journal of Therapeutics. 28(2). e217–e223. 21 indexed citations
2.
Lancaster, Lisa, Jonathan Goldin, Matthias Trampisch, et al.. (2020). Effects of Nintedanib on Quantitative Lung Fibrosis Score in Idiopathic Pulmonary Fibrosis. The Open Respiratory Medicine Journal. 14(1). 22–31. 30 indexed citations
3.
Nair, Girish B. & Jonathan Ilowite. (2012). Pharmacologic Agents for Mucus Clearance in Bronchiectasis. Clinics in Chest Medicine. 33(2). 363–370. 19 indexed citations
4.
Ilowite, Jonathan, et al.. (2009). Pharmacological Treatment Options for Bronchiectasis. Drugs. 69(4). 407–419. 7 indexed citations
5.
Ilowite, Jonathan, et al.. (2008). Bronchiectasis: new findings in the pathogenesis and treatment of this disease. Current Opinion in Infectious Diseases. 21(2). 163–167. 27 indexed citations
6.
Ilowite, Jonathan, R. Clinton Webb, Bruce Friedman, et al.. (2004). Addition of montelukast or salmeterol to fluticasone for protection against asthma attacks: a randomized, double-blind, multicenter study. Annals of Allergy Asthma & Immunology. 92(6). 641–648. 52 indexed citations
7.
Fedullo, Peter F., et al.. (2002). Pulmonary Artery Sarcoma. CHEST Journal. 122(2). 745–747. 63 indexed citations
8.
Littner, Michael R., Jonathan Ilowite, Donald P. Tashkin, et al.. (2000). Long-Acting Bronchodilation with Once-Daily Dosing of Tiotropium (Spiriva) in Stable Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 161(4). 1136–1142. 162 indexed citations
9.
Barker, Alan F., Stanley B. Fiel, Mark H. Gotfried, et al.. (2000). Tobramycin Solution for Inhalation Reduces Sputum Pseudomonas aeruginosa Density in Bronchiectasis. American Journal of Respiratory and Critical Care Medicine. 162(2). 481–485. 239 indexed citations
10.
Smaldone, Gerald C., et al.. (1998). Respirable Mass: Vague and Indefinable in Disease. Journal of Aerosol Medicine. 11(s1). S–105. 7 indexed citations
11.
O’Donnell, Anne E., Alan F. Barker, Jonathan Ilowite, & Robert B. Fick. (1998). Treatment of Idiopathic Bronchiectasis With Aerosolized Recombinant Human DNase I. CHEST Journal. 113(5). 1329–1334. 285 indexed citations
12.
Khullar, Poonam, et al.. (1996). Clostridium difficile infection as a cause of severe sepsis. Intensive Care Medicine. 22(9). 990–994. 25 indexed citations
13.
Ilowite, Jonathan, Michael S. Niederman, & Alan M. Fein. (1991). Delivery of topical antibiotics: pharmacokinetics and clinical problems.. PubMed. 6(3). 158–67. 9 indexed citations
14.
Ilowite, Jonathan, et al.. (1991). Delivered Dose and Regional Distribution of Aerosolized Pentamidine Using Different Delivery Systems. CHEST Journal. 99(5). 1139–1144. 19 indexed citations
15.
Niederman, Michael S., et al.. (1991). Benefits of a Multidisciplinary Pulmonary Rehabilitation Program. CHEST Journal. 99(4). 798–804. 117 indexed citations
16.
Ilowite, Jonathan, Gerald C. Smaldone, Robert J. Perry, William D. Bennett, & W. Michael Foster. (1989). Relationship between Tracheobronchial Particle Clearance Rates and Sites of Initial Deposition in Man. Archives of Environmental Health An International Journal. 44(4). 267–273. 55 indexed citations
17.
Smaldone, Gerald C., et al.. (1989). Generation and Administration of Aerosols for Medical and Physiological Research Studies. Journal of Aerosol Medicine. 2(2). 81–87. 32 indexed citations
18.
Ilowite, Jonathan, et al.. (1989). Permeability of the Bronchial Mucosa to 99m Tc-DTPA in Asthma. American Review of Respiratory Disease. 139(5). 1139–1143. 67 indexed citations
19.
Smaldone, Gerald C., et al.. (1988). Interpretation of "24 Hour Lung Retention" in Studies of Mucociliary Clearance. Journal of Aerosol Medicine. 1(1). 11–20. 89 indexed citations
20.
Antoine, G., David M. Nierman, Jonathan Ilowite, Richard N. Pierson, & A. L. Loomis Bell. (1988). Bilateral Upper Lobe Pneumocystis carinii Pneumonia in a Patient Receiving Inhaled Pentamidine Prophylaxis. CHEST Journal. 94(2). 329–331. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J C Yernault Breakdown of academic impact, for papers by Robert H. Poe Breakdown of academic impact, for papers by Gerard J. Canny Breakdown of academic impact, for papers by Tam Eaton Breakdown of academic impact, for papers by Jeng‐Yuan Hsu Breakdown of academic impact, for papers by D P Heaf Breakdown of academic impact, for papers by F. John McLaughlin Breakdown of academic impact, for papers by Rafał Krenke Breakdown of academic impact, for papers by Paola Faverio Breakdown of academic impact, for papers by Young Sik Park
Rankless by CCL
2026